Novonesis (Novozymes) B

NZM2

Company Profile

  • Business description

    Novonesis was formed in 2024 through the merger of Novozymes and Chr. Hansen. Following the merger, the company became the world leader in industrial enzymes and microbial solutions, with a nearly 50% market share in both. The firm supplies a wide range of industry groups: household care, food and beverages, bioenergy, agriculture and feed, technical and pharmaceuticals. Its biological solutions create value for its customers by improving yield efficiency and performance, while saving energy and generating less waste. The company is headquartered in Denmark, employs around 10,000 people, and works across more than 30 research and development and application centers and 23 manufacturing sites.

  • Contact

    Krogshoejvej 36
    Bagsvaerd2880
    DNK

    T: +45 44460000

    https://www.novozymes.com

  • Sector

    Basic Materials

    Stock type

    Cyclical

  • Industry

    Specialty Chemicals

    Fiscal Year End

    31 December 2025

    Employees

    10,582

Stocks News & Analysis

stocks

Ask the analyst: Can this genius product create the next ASX software king?

Siteminder’s newly released product for hotel owners and travel agents could widen its moat and see revenue accelerate further.
stocks

Impact of ANZ’s huge fine

Working to prevent repeated failures could also improve competitiveness.
stocks

Acquisition a sign of weakness for overvalued ASX share

Acquisition unlikely to improve prospects in the US and detracts from other opportunities.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,091.8030.70-0.34%
CAC 407,818.2278.71-1.00%
DAX 4023,329.24419.62-1.77%
Dow JONES (US)45,757.90125.55-0.27%
FTSE 1009,195.6681.37-0.88%
HKSE26,812.19373.681.41%
NASDAQ22,333.9614.79-0.07%
Nikkei 22544,915.6713.400.03%
NZX 50 Index13,193.0241.87-0.32%
S&P 5006,606.768.52-0.13%
S&P/ASX 2008,816.6031.90-0.36%
SSE Composite Index3,877.5515.680.41%

Market Movers